Pfizer has announced that it will be taking new steps to make its Prevenar 13 vaccine accessible to people in poor countries through a new agreement with the Gavi Alliance. The company has committed to a 20 cent reduction of its per-dose price for the new four-dose vial presentation of the pneumococcal polysaccharide conjugate vaccine…Susan Silbermann, president and general manager of Pfizer Vaccines, said: "We are pleased to support Gavi in our shared goal of protecting the world's most vulnerable children through a sustainable vaccine programme. No child should die - anywhere in the world - from a vaccine-preventable disease."…